Associations of perceived stress and state anger with symptom burden and functional status in patients with heart

Romano Endrighi1,2, Andrew J Dimond1, Andrew J Waters1

  • 1Department of Medical and Clinical Psychology, Uniformed Services University of the Health Sciences , Bethesda , MD , USA.

Psychology & Health
|May 22, 2019
PubMed

Insights

Psychological stress and anger negatively impact heart failure (HF) patients

Area of Science:

  • Cardiology
  • Psychosomatic Medicine
  • Clinical Psychology

Background:

  • Psychosocial stress and anger are known cardiovascular event triggers.
  • The specific impact of these factors on heart failure (HF) exacerbations remains unclear.
  • Understanding these associations is crucial for comprehensive HF management.

Purpose of the Study:

  • To investigate the relationship between perceived stress and anger with functional status and symptoms in heart failure (HF) patients.
  • To determine if perceived stress or anger is a stronger predictor of HF outcomes.

Main Methods:

  • Prospective cohort study (BETRHEART) of 144 HF patients.
  • Biweekly assessments of perceived stress (Perceived Stress Scale; PSS) and state anger (STAXI) over 3 months.
  • Biweekly objective functional status (6-min walk test; 6MWT) and health status (Kansas City Cardiomyopathy Questionnaire; KCCQ) measurements.

Main Results:

  • Higher average perceived stress (PSS) and increases in PSS were linked to worse KCCQ scores.
  • Increased PSS was associated with a poorer 6-min walk test (6MWT) performance.
  • While anger showed associations, perceived stress emerged as a stronger predictor, with anger's effects potentially mediated by stress.

Conclusions:

  • Both perceived stress and anger are significantly associated with poorer functional and health status in HF patients.
  • Perceived stress is a more robust predictor of adverse outcomes in this population.
  • Anger's detrimental effects on HF status may be partly explained by its influence on psychological stress.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
812
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.1K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
751
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
289
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
846
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
239